Home

sep18-hero

THE CASE FOR CONTINUED INNOVATION:
NOVEL AMORPHOUS
SOLID DISPERSION TECHNOLOGIES FOR AN INCREASING INSOLUBLE DRUG PROBLEM

AAPS Publications

sep-18 Publications

Pharmaceutical Additive Manufacturing

An AAPS PharmSciTech mini-review on 3D printing processes.

Read More

Professional Development

sep18-PD

Virtual Teams: The Four Rights

Virtual teams are becoming the new normal in business life. Are we setting them up for success? 

Read More

Pharmaceutical Science Update

Posted By Linda Brown
Found In Microsite: AAPS News Magazine
September 19, 2018 Health programs including medical research will get a funding boost in the congressional deal that covers the fiscal year starting Oct. 1. Now lawmakers need to approve it. The package (H.R. 6157 ) would increase funding for the ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
September 19, 2018 The first National Institutes of Health (NIH) funded study of gene editing technology for treatment of sickle cell disease will start before the end of the year, the agency’s chief said. If scientists can successfully use a gene ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
September 19, 2018 The number of Americans diagnosed with cancer each year will grow to 2.39 million by 2035 without better prevention and treatment options, a leading research group said on Sept. 12. That projection would mark a 37 percent increase ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
September 19, 2018 Companies that sell a psychotropic substance called kratom are getting more federal scrutiny thanks to increasing reports of death, abuse, and false advertising. On Sept. 11, the Food and Drug Administration (FDA) announced it sent ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
September 12, 2018 The Food and Drug Administration (FDA) will soon revise its policy on citizen petitions, which can be “another anti-competitive technique” drugmakers use to block generic approval, an FDA official said on Sept. 5. Citizen petitions ...